BTI
UTHR icon

Blue Trust Inc’s United Therapeutics UTHR Stock Holding History

Blue Trust Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
722
-186
-20% -$105K ﹤0.01% 559
2026
Q1 		$538K Hold
908
– – 0.01% 460
2025
Q4 		$442K Sell
908
-260
-22% -$121K 0.01% 526
2025
Q3 		$490K Sell
1,168
-67
-5% -$22.5K 0.01% 492
2025
Q2 		$355K Buy
1,235
+86
+7% +$25.7K ﹤0.01% 574
2025
Q1 		$354K Hold
1,149
– – ﹤0.01% 516
2024
Q4 		$405K Sell
1,149
-256
-18% -$94.1K 0.01% 432
2024
Q3 		$448K Buy
1,405
+437
+45% +$148K 0.01% 515
2024
Q2 		$222K Buy
968
+285
+42% +$75.4K ﹤0.01% 666
2024
Q1 		$157K Buy
683
+179
+36% +$40.4K ﹤0.01% 586
2023
Q4 		$114K Buy
504
+46
+10% +$10.6K ﹤0.01% 635
2023
Q3 		$101K Buy
458
+279
+156% +$64.3K ﹤0.01% 616
2023
Q2 		$40K Sell
179
-1,196
-87% -$265K ﹤0.01% 775
2023
Q1 		$382K Buy
1,375
+453
+49% +$112K 0.01% 350
2022
Q4 		$193K Buy
922
+597
+184% +$151K ﹤0.01% 464
2022
Q3 		$77K Buy
325
+171
+111% +$38.2K ﹤0.01% 619
2022
Q2 		$28K Buy
+154
New +$31.3K ﹤0.01% 858

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Blue Trust Inc's UTHR Position: Q2 2026 in Review

Blue Trust Inc reduced its United Therapeutics (UTHR) stake by 20% in Q2 2026, selling an estimated $105K and leaving 722 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Blue Trust Inc first reported a position in UTHR in Q2 2022 and has held it in 17 quarters since. The position peaked at $538K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Blue Trust Inc held 722 shares of United Therapeutics worth $391K as of Q2 2026.
  • Blue Trust Inc sold 186 United Therapeutics shares in Q2 2026, an estimated $105K.
  • United Therapeutics made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #559 holding.
  • Blue Trust Inc first reported a position in United Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's United Therapeutics position peaked at $538K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.